What, according to you, were the various challenges faced by the companies involved in the disease diagnostics space during the pandemic?
As COVID-19 was a novel virus, detecting, containing, treating and managing the disease proved to be difficult for everyone. Lockdowns across the world to contain the disease posed additional logistical burden. Test, Trace and Treat became the diktat to fight COVID-19 and 'Testing' came under the spotlight.
Initially we faced a challenge in procurement and supply of test kits, reagents and other consumables. This was resolved by working closely with our reliable and sturdy network of suppliers. ICMR quickly validating the newly launched test kits also came in as a huge help.
COVID also forced us to think outside the box- literally, when we set-up a BSL2 level Container Lab in our National Reference Lab in Rohini, Delhi. This helped us processing greater volumes of samples simply by providing a place to unbox and add buffer to the samples before the actual testing started. With this, we were able to insulate our lab premises and staff from threat of COVID.
As everyone was dealing with the unknown, teething troubles with various states in terms of compliance, operations, reporting and pricing were also faced.
Which approaches and techniques are considered suitable (and safe) for diagnosis of infectious diseases today?
Infectious diseases are caused by Bacteria, Viruses, Fungi and Parasites and the clinical symptoms are often a mix complex of fever, cough, cold, diarrhea, rashes, etc. which are generally site specific. The best way to diagnose infectious diseases is to go for site-specific sampling and subject it to PCR (Polymerase Chain Reaction) that detects genetic material from a specific organism. This is the fastest, most sensitive and specific way to detect the causative agent of the infection.
この記事は Healthcare Radius の December 2022 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Healthcare Radius の December 2022 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
KIMSHEALTH launches electrophysiology lab with 3D mapping
'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.
Molbio boosts Goa's healthcare system with CSR initiatives
The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies
USV introduces affordable heart failure medication
This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.
City Imaging & Clinical Labs to expand services to 50 hospitals
The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.
Oncare raises $1 million in seed funding, to set up 10 units
Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.
Nutrabay forays into Ayurvedic supplements market with Shilajit
Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?